ARTICLE | Company News
Mercachem B.V., ProQinase cancer news
May 20, 2013 7:00 AM UTC
CROs ProQinase and Mercachem received a €2.5 million ($3.3 million) grant from the EU's Eurostars program to develop a small molecule drug discovery platform targeted against epigenetic enzyme familie...